Atlas Trials

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Clinical trial NCT01454089 · COMPLETED

Trial details

NCT number
NCT01454089
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Urologic NeoplasmsMetastatic Bladder CancerUrinary Tract Neoplasms
Start date
2011-10-01
Primary completion
2014-11-01
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.